Evgeniy A. Gusakov

Evgeniy A. Gusakov

Auto-generated profile, based on publicly available information

Evgeniy A. Gusakov

Southern Federal University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Russian Journal of Bioorganic Chemistry
Verified
Journal Article
Closed access
PDF file
YSYu. A. Sayapin
Yu. A. Sayapin
EGE. A. Gusakov
E. A. Gusakov
IDI. V. Dorogan
I. V. Dorogan
ITI. O. Tupaeva
I. O. Tupaeva
MTM. G. Teimurazov
M. G. Teimurazov
VMV. I. Minkin
V. I. Minkin
2-(4 H-1,3-Benzoxazin-4-on-2-yl)-4,5,6-trichloro-1,3-tropolone, structural properties of which were studied using 1H NMR, IR-spectroscopy, mass spectrometry, and quantum chemistry has been obtained...

1 July 2018 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
АTА. А. Tsaturyan
А. А. Tsaturyan
ASAlyona A. Starikova
Alyona A. Starikova
ЕGЕ. А. Gusakov
Е. А. Gusakov
VMV. I. Minkin
V. I. Minkin

1 February 2015 in Doklady Chemistry
Verified
Journal Article
Closed access
PDF file
YSYu. A. Sayapin
Yu. A. Sayapin
ITI. O. Tupaeva
I. O. Tupaeva
EGE. A. Gusakov
E. A. Gusakov
GSG. V. Shilov
G. V. Shilov
VTV. V. Tkachev
V. V. Tkachev
VMV. I. Minkin
V. I. Minkin

1 July 2016 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
YSYu. A. Sayapin
Yu. A. Sayapin
SNStanislav Nikolaevskii
Stanislav Nikolaevskii
NMN. I. Makarova
N. I. Makarova
EGE. A. Gusakov
E. A. Gusakov
ITI. O. Tupaeva
I. O. Tupaeva
VMV. I. Minkin
V. I. Minkin
The structure of bis[2-(1,3-benzoxazol-2-yl-κ)-4,5-dichloro-3-(ethoxycarbonyl)phenolato-κ]-zinc(II) was determined by IR and H and C NMR spectroscopy, and its structural characteristics were estimated by quantum chemical calculations. The complex showed photoluminescence properties.

1 March 2021 in Tetrahedron
Verified
Journal Article
Closed access
YSYury A. Sayapin
Yury A. Sayapin
EGEugeny A. Gusakov
Eugeny A. Gusakov
ITInna O. Tupaeva
Inna O. Tupaeva
OKOlga Yu Karlutova
Olga Yu Karlutova
IDIrina V. Dubonosova
Irina V. Dubonosova
SAS. M. Aldoshin
S. M. Aldoshin

17 July 2022 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
VMV. I. Minkin
V. I. Minkin
ELE. A. Lukbanova
E. A. Lukbanova
YSYu. A. Sayapin
Yu. A. Sayapin
EGE. A. Gusakov
E. A. Gusakov
ЮСЮ. А. Саяпин
Ю. А. Саяпин
The aim. To study the toxicity of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone in vitro and in vivo.Materials and methods. 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone was synthesized using a method for expanding the o-quinone cycle during the reaction between 5-nitro-2,6,8-trimethyl4-chloroquinoline and 3,4,5,6-tetrachloro-1,2-benzoquinone while boiled in dioxane. An in vitro experiment was carried out in the human A549 cell line. Cell viability was assessed using the MTT colorimetric assay by reducing the optical density of the experimental samples compared with the control ones. Acute toxicity was studied on 20 BALB/c Nude male mice. The test compound was administered once orally as a suspension in 1% starch gel at three doses: 0.0055 (group 1), 0.055 (group 2) and 0.55 mg / g (group 3). The control group (group 4) received a placebo.Results. We synthesized a new compound, 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone. Its structure was established by 1 H nuclear magnetic resonance (NMR), infrared (IR) spectroscopy, and mass spectrometry. The yield was 19.8 g (52%), the melting point was 205–207 ºС, bright yellow crystals (benzene) were observed. The half-maximal inhibitory concentration (IC50) of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone was 0.21 ± 0.01 μM, which was significantly lower (р < 0.05) than the IC50 of cisplatin (3.84 ± 0.23). Following the in vivo experiment, no toxic effect of tropolone was detected when administered once at a dose of 0.0055, 0.055, and 0.55 mg / g. Conclusion. 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone demonstrated cytotoxic effects on the A549 cell line at a lower IC50 than cisplatin which is widely used in treatment of cancers, including lung cancer. Insolubility of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone in water and the absence of its toxic effect in the studied modes determine the scope of its application for further study of cumulative and antitumor effects.